News

Generics save US 1.2 trillion over last 10 years

Published on 2014/07/29

Generics have saved consumers and the US healthcare system US$217 billion in 2012 and have saved the US in excess of US$1.2 trillion between 2003 and 2012, according to a report by the Generic Pharm...

4 views

Read more →

Guiding principles for biosimilars development

Published on 2014/07/21

In contrast to chemically synthesized small-molecule drugs, biologicals have complex structures of high molecular weight. Therefore, even small changes in the production processes may lead to differ...

7 views

Read more →

Confusion exists in Brazil over generics

Published on 2014/07/16

Brazilians are confused about generics and are unable to distinguish between a generic drug and a brand-name drug [1].  The Brazilian pharmaceutical market is the third largest in the Americas reg...

6 views

Read more →

Australia to adopt EMA’s monoclonal antibody guideline

Published on 2014/07/14

The Therapeutic Goods Administration (TGA), Australia’s regulatory body for therapeutic goods, announced on 14 February 2014 that it was carrying out public consultations on the adoption of Europe...

4 views

Read more →

France to allow biosimilars substitution

Published on 2014/07/10

Pharmacists in France will now be allowed to substitute a biosimilar for the prescribed (reference) biological under certain conditions, including only when initiating a course of treatment and that...

1 views

Read more →

Impact of coupons on adherence to statins

Published on 2014/07/08

Once patents expire, in an effort to maintain market share, originator manufacturers often initiate promotional activities such as drug samples and co-pay discount coupons that reduce patients out-o...

5 views

Read more →

Use of formularies could increase use of biosimilars

Published on 2014/07/04

Whether or not the US Food and Drug Administration (FDA) permits automatic substitution of biosimilars, healthcare systems can still consider using formularies as a way to increase the use of more aff...

1 views

Read more →

Biosimilars: what physicians need to know

Published on 2014/06/03

A biosimilar is a medicinal product that is similar to a biological medicinal product that has already been authorized. Biologicals are comprised of proteins, such as hormones (growth hormones, in...

1 views

Read more →

Effects of income, competition and procurement on drug prices in emerging markets

Published on 2014/05/29

Drugs are least affordable relative to income in low-income countries, according to an analysis of income, competition and procurement on drug prices in emerging markets [1]. Pharmaceutical pri...

1 views

Read more →

Switching to generic cyclosporine A after heart transplant safe

Published on 2014/05/27

Cyclosporine A is an immunosuppressant drug widely used in organ transplantation to prevent rejection. A study of switching between originator and generic drugs showed that the generic was well tole...

3 views

Read more →

EU problematic patent settlements remain at low level

Published on 2014/05/22

The European Commission’s (EC) fourth monitoring exercise of patent settlements in the pharmaceutical sector has shown the number of potentially problematic settlements under EU antitrust rules ...

1 views

Read more →

Biosimilar trastuzumab approved in Korea

Published on 2014/05/20

South Korean biotechnology company Celltrion announced on 15 January 2014 that it had received approval for its biosimilar monoclonal antibody Herzuma (trastuzumab) with the Korean Ministry of Food ...

12 views

Read more →